Vestiage Secures $10 Million in Advertising Funding from Media Funding Group
NEWPORT BEACH, Calif., June 26, 2014-- Vestiage™, Inc. (“VEST”), the “Healthy-Aging” Company, announced today that it has re-negotiated its agreement with Media Funding Group and secured an expanded commitment of $10 million in total media from Media Funding Group, a NWBB company. The funds will be made available immediately. Media Funding Group provides advertising expertise and private funding access for advertising and marketing campaigns.
“After getting more deeply involved with Vestiage, and seeing the growth in their commitments from national and other retailers, it made sense for Vestiage and Media Funding Group to structure a solution that covered both direct response advertising and supported the retail expansion and branding needs of RegiMEN™ and future brand launches,” said Marc Hatch, the Media Funding Group Vice President of Funding.
Scott Kimball, CEO of Vestiage, Inc. said, “We recently have experienced a swell in commitments from national and other retailers for the RegiMEN brand. In order to meet the changing media needs of our Company to support this expanding retail presence, we were able to secure an increase in the funding commitment from Media Funding Group that also covers brand and retail oriented advertising. Our RegiMEN television commercial is now entering production and we expect to begin airing it in August. In the meantime, we will continue to spend on national radio media.”
Vestiage sells RegiMEN in both the retail and direct-to-consumer channels. In the first quarter of 2014, the Company started its national radio campaign for the RegiMEN brand and saw strong initial acceptance from consumers as evidenced by an increase in gross revenue with both retail and direct response revenue growth contributing to the increase in sales. Additionally, the RegiMEN brand experienced good retention in monthly reorders. The Company is currently executing on a national retail rollout strategy that began February 3, 2014. RegiMEN is currently available at www.RegiMENLife.com and at select GNC and all Hi Health retail stores.
About Media Funding Group
Media Funding Group provides private funding access for Advertising and Marketing campaigns in exchange for a flexible blend of re-payment options including Equity Participation, Revenue Sharing or flexible payments on Revolving Credit Lines. For more information, please visit www.mediafundinggroup.com or call 1-360-835-1270.
Vestiage™ (stock symbol "VEST") is a publicly traded healthy aging company. The Company offers premium branded science-based nutraceuticals to a premium consumer base through multiple channels. The Company is a sales, marketing, and distribution company specializing in bringing science-based products to the healthy aging consumer. The Company utilizes key partners to integrate production, fulfillment, customer service, advertising, sales, media, marketing, distribution, new product development and acquisitions. Vestiage is focused on the use of the best ingredients from the ocean and earth, including cutting edge, patented, clinically proven ingredients to produce highly potent, and elegantly formulated products. Using potency and novel ingredient combinations, Vestiage™ creates and distributes nutraceuticals such as RegiMEN for men (www.BuyRegimen.com) and the multifunctional Monterey Bay Nutraceuticals line for women. (www.MontereyBayNutra.com). Vestiage™ brands address the top “in demand” healthy aging concerns of men and women. Vestiage™ research is focused on extending the active period of a human life covering both the cognitive and physical realms. To learn more, visit the Company website, www.vestiageinc.com.
As with many fast growing companies, our growth is dependent upon adequate funding for inventory, media, general overhead, professional fees, technology, salaries and other expenses related to the business. Should we be unable in the future to obtain appropriate funding to pay our expenses and media at current levels, our growth, and our financial stability, may be negatively impacted.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward looking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.
Scott Kimball, CEO
Venture Capital Database
Venture Capital Deals Spreadsheet